Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1420447 | 0.87 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL45388 | 0.84 | TSHR (0.41) | TSHRALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL5006489 | 0.79 | — | — | |
| SCHEMBL5006496 | 0.79 | — | — | |
| SCHEMBL24603372 | 0.79 | TSHR (0.41) | TSHRALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL4556468 | 0.79 | TSHR (0.41) | TSHRALDH1A1TP53CYP3A4MAPK1 | |
| Alcohol SCHEMBL7187474 | 0.77 | TSHR (0.35) | TSHRALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL3518097 | 0.70 | TSHR (0.33) | TSHRALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL9318291 | 0.70 | TSHR (0.33) | TSHRALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL24603363 | 0.68 | TSHR (0.32) | TSHRALDH1A1TP53CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1342471-B1 | Nanocapsules based on polyol polyester, and cosmetic and dermatological compositions containing same | OREAL (FR) | 2005-06-08 | — | — | EP | claimed |
| US-20030224060-A1 | Polyester polyol nanocapsules, compositions thereof, and methods of use | L'OREAL (FR) | 2003-12-04 | — | — | US | claimed |
| EP-1342471-A1 | Nanocapsules based on polyol polyester, and cosmetic and dermatological compositions containing same | L'OREAL (FR) | 2003-09-10 | — | — | EP | claimed |
| EP-2011565-B1 | Core/skin type capsules and preparation method | OREAL (FR) | 2010-11-03 | — | — | EP | disclosed |
| US-20090047341-A1 | CAPSULES OF CORE/SHELL TYPE AND PREPARATION PROCESS | L'OREAL (FR) | 2009-02-19 | — | — | US | disclosed |
| EP-2011565-A1 | Core/skin type capsules and preparation method | L'OREAL (FR) | 2009-01-07 | — | — | EP | disclosed |
| EP-1342471-B1 | Nanocapsules based on polyol polyester, and cosmetic and dermatological compositions containing same | OREAL (FR) | 2005-06-08 | — | — | EP | disclosed |
| US-20030224060-A1 | Polyester polyol nanocapsules, compositions thereof, and methods of use | L'OREAL (FR) | 2003-12-04 | — | — | US | disclosed |
| EP-1342471-A1 | Nanocapsules based on polyol polyester, and cosmetic and dermatological compositions containing same | L'OREAL (FR) | 2003-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090047341-A1 | CAPSULES OF CORE/SHELL TYPE AND PREPARATION PROCESS | SAMM50, CFH, DOHH | TSHR 4742/4885ALDH1A1 3090/4885TP53 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.